The global Plant-Based API Market is projected to reach USD 57.5 billion by 2034, growing at a CAGR of 5.8% from 2025. Driven by the demand for natural pharmaceuticals and organic supplements, the market sees North America leading with a 34.13% share. Key segments include soy-sourced APIs, powder formulations, and applications in chronic disease management. Discover insights on market drivers, the US and Japan outlook, and major competitive players in botanical drug development.
